Morgan Stanley Sticks to Its Hold Rating for Pacific Biosciences (PACB)
Morgan Stanley analyst Tejas Savant maintained a Hold rating on Pacific Biosciences (PACB – Research Report) today and set a price target of ...
Pacific Biosciences of California Full Year 2024 Earnings: EPS Beats Expectations
Full Year 2024 Results Key Financial Results Revenue: US$154.0m ...
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 13, 2025 Pacific Biosciences of California, Inc. beats earnings expectations.
Pacific Biosciences of California Inc (PACB) Q4 2024 Earnings Report Preview: What To Expect
Pacific Biosciences of California Inc (NASDAQ:PACB) is set to release its Q4 2024 earnings on Feb 13, 2025. The consensus ...
Pacific Biosciences: Q4 Earnings Snapshot
MENLO PARK, Calif. (AP) — MENLO PARK, Calif. (AP) — Pacific Biosciences of California Inc. (PACB) on Thursday reported fourth-quarter profit of $3.6 million. The Menlo Park, California-based company ...